UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods

Annals of oncology, 2011-06, Vol.22 (6), p.1295-1301

2011

Volltextzugriff (PDF)

Evaluation of the cardiovascular health study (CHS) instrument and the Vulnerable Elders Survey-13 (VES-13) in elderly cancer patients. Are we still missing the right screening tool?

Annals of oncology, 2013-02, Vol.24 (2), p.494-500

2013

Volltextzugriff (PDF)

SP-0252 THE LIMITS IN DELIVERY CHEMOTHERAPY IN THE ELDERLY: THE BREAST MODEL

Radiotherapy and oncology, 2012-05, Vol.103, p.S100-S100

2012

Volltextzugriff (PDF)

Feasibility and safety of dose-dense docetaxel after conventional epirubicin and cyclophosphamide as adjuvant treatment for early breast cancer patients

Breast (Edinburgh), 2013-10, Vol.22 (5), p.926-932

2013

Volltextzugriff (PDF)

Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial

The lancet oncology, 2021-02, Vol.22 (2), p.267-276

2021

Volltextzugriff (PDF)

Overcoming endocrine resistance in breast cancer patients

Journal of geriatric oncology, 2012-10, Vol.3, p.S12-S13

2012

Volltextzugriff (PDF)

Toward a genome-based treatment landscape for renal cell carcinoma

Critical reviews in oncology/hematology, 2019-10, Vol.142, p.141-152

2019

Volltextzugriff (PDF)

Abstract P6-14-01: The effect trial: A randomized phase II trial evaluating two different doses of weekly (W) NAB-paclitaxel (NP) as first-line chemotherapy in older breast cancer (BC) patients (pts)

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P6-P6-14-01

2018

Volltextzugriff (PDF)

Designing clinical trials for triple negative breast cancer: evidence and issues

European journal of cancer supplements, 2008, Vol.6 (7), p.165-166

2008

Volltextzugriff (PDF)

Negative prognostic factors and resulting clinical outcome in patients (pts) with metastatic renal cell carcinoma (mRCC) included in the Italian nivolumab expanded access program (EAP)

Annals of oncology, 2017-09, Vol.28, p.v314-v314

2017

Volltextzugriff (PDF)

52P Real-world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group

ESMO open, 2023-02, Vol.8 (1), p.100832, Article 100832

2023

Volltextzugriff (PDF)

Pattern of Dihydropyrimidine Dehydrogenase Genetic Variants in Patients with Various Degrees of Tolerability of Fluoropyrimidine Treatment

Annals of oncology, 2014-09, Vol.25, p.iv77

2014

Volltextzugriff (PDF)

Pharmacokinetic results of a phase I trial of sorafenib (S) in combination with dacarbazine (DTIC) in patients with advanced metastatic melanoma or other solid tumors

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.2563-2563

2007

Volltextzugriff (PDF)

Sorafenib (S) and dacarbazine (D) combination in patients (pts) with advanced malignant solid tumors: Phase I study with tumor biopsy genomic analysis and dynamic contrast enhanced ultrasonography (DCE-US)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.3556-3556

2007

Volltextzugriff (PDF)

Evaluation of the cardiovascular health study (CHS) instrument and the Vulnerable Elders Survey-13 (VES-13) in elderly cancer patients. Are we still missing the right screening tool?

Annals of oncology, 2013-02, Vol.24 (2), p.494

2013

Volltextzugriff (PDF)

228PPATTERN OF DIHYDROPYRIMIDINE DEHYDROGENASE GENETIC VARIANTS IN PATIENTS WITH VARIOUS DEGREES OF TOLERABILITY OF FLUOROPYRIMIDINE TREATMENT

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv77-iv77

2014

Volltextzugriff (PDF)

Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study

The lancet oncology, 2014-12, Vol.15 (13), p.1521-1532

2014

Volltextzugriff (PDF)

Spatial genomic heterogeneity within localized, multifocal prostate cancer

Nature genetics, 2015-07, Vol.47 (7), p.736-745

2015

Volltextzugriff (PDF)

Prognostic Significance of Tonsil Expression and the Homologous Recombination Pathway in Intermediate-Risk Prostate Cancer Recurrence

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S113-S113

2016

Volltextzugriff (PDF)

Positive demographic effects of nest surveillance campaigns to counter illegal harvest of the Bonelli's eagle in Sicily (Italy)

Animal conservation, 2018-04, Vol.21 (2), p.120-126

2018

Volltextzugriff (PDF)

Population size and breeding performance of the Lanner Falcon Falco biarmicus in Sicily: conservation implications

Bird study, 2017-07, Vol.64 (3), p.339-343

2017

Volltextzugriff (PDF)

PD-0300: NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer

Radiotherapy and oncology, 2014, Vol.111, p.S116-S117

2014

Volltextzugriff (PDF)

MC13-0009 A prognostic CNA signature sub-stratifies intermediate-risk prostate cancer

European journal of cancer (1990), 2013-11, Vol.49, p.S14-S14

2013

Volltextzugriff (PDF)

Wintering of Egyptian vultures (Neophron percnopterus) in Sicily: new data

Arxius de miscel·lània zoològica, 2016-12, Vol.14, p.114-116

2016

Volltextzugriff (PDF)

12p-Amplicon structure analysis in testicular germ cell tumors of adolescents and adults by array CGH

Oncogene, 2003-10, Vol.22 (48), p.7695-7701

2003

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(36)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Life Sciences & Biomedicine
(12)
Hematology, Oncology And Palliative Medicine
(8)
Humans
(7)
Oncology
(7)
Biological And Medical Sciences
(5)
Adult
(4)
Aged
(4)
Female
(4)
Male
(4)
Middle Aged
(4)
Tumors
(4)
Biochemistry & Molecular Biology
(3)
Cancer Therapies
(3)
Fundamental And Applied Biological Sciences. Psychology
(3)
Medical Sciences
(3)
Neophron Percnopterus
(3)
Patients
(3)
Aged, 80 And Over
(2)
Animals
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods

Evaluation of the cardiovascular health study (CHS) instrument and the Vulnerable Elders Survey-13 (VES-13) in elderly cancer patients. Are we still missing the right screening tool?

SP-0252 THE LIMITS IN DELIVERY CHEMOTHERAPY IN THE ELDERLY: THE BREAST MODEL

Feasibility and safety of dose-dense docetaxel after conventional epirubicin and cyclophosphamide as adjuvant treatment for early breast cancer patients

Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial

Overcoming endocrine resistance in breast cancer patients

Toward a genome-based treatment landscape for renal cell carcinoma

Abstract P6-14-01: The effect trial: A randomized phase II trial evaluating two different doses of weekly (W) NAB-paclitaxel (NP) as first-line chemotherapy in older breast cancer (BC) patients (pts)

Designing clinical trials for triple negative breast cancer: evidence and issues

Negative prognostic factors and resulting clinical outcome in patients (pts) with metastatic renal cell carcinoma (mRCC) included in the Italian nivolumab expanded access program (EAP)

52P Real-world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group

Pattern of Dihydropyrimidine Dehydrogenase Genetic Variants in Patients with Various Degrees of Tolerability of Fluoropyrimidine Treatment

Pharmacokinetic results of a phase I trial of sorafenib (S) in combination with dacarbazine (DTIC) in patients with advanced metastatic melanoma or other solid tumors

Sorafenib (S) and dacarbazine (D) combination in patients (pts) with advanced malignant solid tumors: Phase I study with tumor biopsy genomic analysis and dynamic contrast enhanced ultrasonography (DCE-US)

Evaluation of the cardiovascular health study (CHS) instrument and the Vulnerable Elders Survey-13 (VES-13) in elderly cancer patients. Are we still missing the right screening tool?

228PPATTERN OF DIHYDROPYRIMIDINE DEHYDROGENASE GENETIC VARIANTS IN PATIENTS WITH VARIOUS DEGREES OF TOLERABILITY OF FLUOROPYRIMIDINE TREATMENT

Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study

Spatial genomic heterogeneity within localized, multifocal prostate cancer

Prognostic Significance of Tonsil Expression and the Homologous Recombination Pathway in Intermediate-Risk Prostate Cancer Recurrence

Positive demographic effects of nest surveillance campaigns to counter illegal harvest of the Bonelli's eagle in Sicily (Italy)

Population size and breeding performance of the Lanner Falcon Falco biarmicus in Sicily: conservation implications

PD-0300: NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer

MC13-0009 A prognostic CNA signature sub-stratifies intermediate-risk prostate cancer

Wintering of Egyptian vultures (Neophron percnopterus) in Sicily: new data

12p-Amplicon structure analysis in testicular germ cell tumors of adolescents and adults by array CGH

Suchergebnisse filtern